TLR5 agonist in combination with anti-PD-1 treatment enhances anti-tumor effect through M1/M2 macrophage polarization shift and CD8+ T cell priming
Article in Cancer Immunology, Immunotherapy (April 2024)
The most recent citing publications are shown below. View all 403 publications that cite this research output on Dimensions.
Article in Cancer Immunology, Immunotherapy (April 2024)
Article in Frontiers in Oncology (April 2024)
Preprint in Research Square (March 2024)